Print Page      Close Window     

Investor Relations

Corporate Profile
Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrated medical technology company focused on developing and commercializing novel technologies for weight loss. Obalon has launched the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity. The Obalon management team has over 150 combined years of experience in developing and commercializing novel medical technologies with a track record of financial and clinical excellence. For more information, please visit www.obalon.com.
IR Kit
Obalon Overview
First Quarter 2017 Press Release
424B Filing

Stock Quote
OBLN (Common Stock) $11.01  + 0.01 (0.09%)
ExchangeNASDAQ
Volume434
Today's Open$11.00
Previous Close$11.00
Data as of 06/26/17 9:40 a.m. ET    Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.


Stock Chart
Stock chart for: OBLN.O.  Currently trading at $11.01 with a 52 week high of $15.88 and a 52 week low of $8.27.

Upcoming Events
There are currently no events scheduled.